Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 1/20 | 0.47 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | CDC25C | P30307 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.39 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.39 |
| ▸ | ITGAL | P20701 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12995999 | 0.89 | AMY1A (0.46) | AMY1ANPSR1HTTSMN1; SMN2CA12 | |
| SCHEMBL2795115 | 0.86 | NPSR1 (0.55) | AMY1ANPSR1HTTSMN1; SMN2CA12 | |
| SCHEMBL18754079 | 0.81 | AMY1A (0.49) | AMY1ANPSR1CA12CA2GAA | |
| SCHEMBL13896556 | 0.81 | AMY1A (0.49) | AMY1ANPSR1HTTSMN1; SMN2CA12 | |
| SCHEMBL24454069 | 0.80 | AMY1A (0.47) | AMY1ANPSR1CA12CA2GAA | |
| Acetic Acid SCHEMBL11587316 | 0.79 | NPSR1 (0.49) | AMY1ANPSR1HTTCA12CA2 | |
| Hydrochloric Acid SCHEMBL28917664 | 0.79 | AMY1A (0.46) | AMY1ANPSR1CA12CA2GAA | |
| SCHEMBL5194552 | 0.78 | CA12 (0.69) | TERTCA12CA2PKMCA9 | |
| SCHEMBL10949866 | 0.78 | AMY1A (0.52) | AMY1AHTTGAAMEN1KMT2A | |
| SCHEMBL15383498 | 0.78 | AMY1A (0.52) | AMY1ANPSR1HTTSMN1; SMN2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200405707-A1 | DIAZINYL AMINO ACRIDINES AND MEDICAL USES THEREOF | MYCURAL THERAPEUTICS AB (SE) | 2020-12-31 | — | — | US | disclosed |
| WO-2019145375-A1 | DIAZINYL AMINO ACRIDINES AND MEDICAL USES THEREOF | LARSSON LARS GUNNAR OLOF (SE) | 2019-08-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200405707-A1 | DIAZINYL AMINO ACRIDINES AND MEDICAL USES THEREOF | MYC, MYCBP, MEN1 | TERT 116/4885AMY1A 356/4885NPSR1 874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.